Ruxolitinib: a targeted treatment option for patients with polycythemia vera

Kris Vaddi,1 Srdan Verstovsek,2 Jean-Jacques Kiladjian3 1Drug Discovery, Incyte Corporation, Wilmington, DE, 2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; 3Clinical Investigations Center, Hôpital Saint-Louis et Université Paris Diderot, Pa...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Vaddi K, Verstovsek S, Kiladjian JJ
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Dove Medical Press 2016-05-01
coleção:	Blood and Lymphatic Cancer: Targets and Therapy
Assuntos:	Myeloproliferative disorder polycythemia vera ruxolitinib
Acesso em linha:	https://www.dovepress.com/ruxolitinib-a-targeted-treatment-option-for-patients-with-polycythemia-peer-reviewed-article-BLCTT
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!